» Articles » PMID: 29802541

The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application

Overview
Publisher Springer
Date 2018 May 27
PMID 29802541
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are now accepted as potential biomarkers in cardiovascular disease development, especially in atherosclerosis. Atherosclerosis is a leading cause of cardiovascular disease-related death and morbidity, accounting for one-fifth of all deaths globally. Therefore, the biomarkers for the management of atherosclerosis is urgently needed. Exosomes are reported to play key roles cell-to-cell communication in atherosclerosis with lipid bilayer membranous vesicles containing nucleic acids, proteins, and lipid contents, which are released from all most of multiple kinds of living cells. This review aims to discuss the potential roles of exosome-derived miRNA, protein, and DNA as biomarkers in atherosclerosis pathogenesis, diagnosis, and therapy.

Citing Articles

The Crosstalk Between Endothelial Cells, Smooth Muscle Cells, and Macrophages in Atherosclerosis.

Gong S, Li Y, Yan K, Shi Z, Leng J, Bao Y Int J Mol Sci. 2025; 26(4).

PMID: 40003923 PMC: 11855868. DOI: 10.3390/ijms26041457.


Circular RNAs in human diseases.

Wang Y, Zhang J, Yang Y, Liu Z, Sun S, Li R MedComm (2020). 2024; 5(9):e699.

PMID: 39239069 PMC: 11374765. DOI: 10.1002/mco2.699.


The Increasing Diagnostic Role of Exosomes in Inflammatory Diseases to Leverage the Therapeutic Biomarkers.

Wang Y, Ma H, Zhang X, Xiao X, Yang Z J Inflamm Res. 2024; 17:5005-5024.

PMID: 39081872 PMC: 11287202. DOI: 10.2147/JIR.S475102.


Clinical Applications of Exosomes: A Critical Review.

Lee K, Chan L, Hung L, Phoebe L, Park Y, Yi K Int J Mol Sci. 2024; 25(14).

PMID: 39063033 PMC: 11277529. DOI: 10.3390/ijms25147794.


Amniotic fluid-derived small extracellular vesicles for predicting postnatal severe outcome of congenital diaphragmatic hernia.

Matsuo S, Yokoi A, Yoshida K, Kitagawa M, Asano-Inami E, Miura M J Extracell Biol. 2024; 3(6):e160.

PMID: 38947173 PMC: 11212330. DOI: 10.1002/jex2.160.


References
1.
Yin M, Loyer X, Boulanger C . Extracellular vesicles as new pharmacological targets to treat atherosclerosis. Eur J Pharmacol. 2015; 763(Pt A):90-103. DOI: 10.1016/j.ejphar.2015.06.047. View

2.
Gao S, Wassler M, Zhang L, Li Y, Wang J, Zhang Y . MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis. Atherosclerosis. 2014; 232(1):171-9. PMC: 4334121. DOI: 10.1016/j.atherosclerosis.2013.11.029. View

3.
Wolf P . The nature and significance of platelet products in human plasma. Br J Haematol. 1967; 13(3):269-88. DOI: 10.1111/j.1365-2141.1967.tb08741.x. View

4.
Chyrchel B, Toton-Zuranska J, Kruszelnicka O, Chyrchel M, Mielecki W, Kolton-Wroz M . Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report. Platelets. 2014; 26(6):593-7. DOI: 10.3109/09537104.2014.974527. View

5.
Goetzl E, Schwartz J, Mustapic M, Lobach I, Daneman R, Abner E . Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease. FASEB J. 2017; 31(8):3689-3694. PMC: 5503715. DOI: 10.1096/fj.201700149. View